These novel findings first investigated the role of miR-21 in p53/Bcl-2/Bax pathway and characterized their interaction in ischemic neuronal injury, suggesting that miR-21/p53 may be attractive therapeutic molecules for treatment of ischemic stroke. Here, TP53 is linked to ischemic stroke.